531
Views
26
CrossRef citations to date
0
Altmetric
Original

RF-power and temperature data analysis of 444 patients with primary cervical cancer: Deep hyperthermia using the Sigma-60 applicator is reproducible

, , , &
Pages 623-643 | Received 20 Sep 2007, Accepted 26 Nov 2007, Published online: 09 Jul 2009

Figures & data

Table I.  The number of primary cervical cancer patients/treatments as analyzed in this study, per weight-group and time-period, in which the Sigma-60 applicator and four configurations of the BSD-2000 system used by the Rotterdam Hyperthermia Group from 1991 to 2005.

Table II.  Average values of patients’ characteristics, RF-power, and temperature data per treatment.

Figure 1. Average of (a) net integrated power, (b) net integrated power per weight, and (c) vagina T50 in the three weight-groups treated with the four configurations of the BSD-2000 and Sigma-60 applicator.

Figure 1. Average of (a) net integrated power, (b) net integrated power per weight, and (c) vagina T50 in the three weight-groups treated with the four configurations of the BSD-2000 and Sigma-60 applicator.

Table III.  Average values of patients’ characteristics, RF-power, and temperature data per treatment for the four configurations of the BSD-2000.

Figure 2. Averages of (a) net integrated power, (b) net integrated power per weight, and (c) vagina T50, in primary cervical cancer patients for the three weight-groups (WG I: W < 61 kg, WG II: 61 ≤ W ≤ 70 kg, WG III: W > 70 kg).

Figure 2. Averages of (a) net integrated power, (b) net integrated power per weight, and (c) vagina T50, in primary cervical cancer patients for the three weight-groups (WG I: W < 61 kg, WG II: 61 ≤ W ≤ 70 kg, WG III: W > 70 kg).

Table IV.  Average values of patients’ characteristics, RF-power, and temperature data per treatment for the three weight-groups. Numbers in parentheses show 1 SD.

Table V.  Average values of patients’ characteristics, RF-power, and temperature data per treatment over the 15 years application of loco-regional deep hyperthermia by the Rotterdam Hyperthermia Group.

Figure 3. Average of (a) net integrated power (b), net integrated power per weight, and (c) vagina T50, over the years in primary cervical cancer patients treated with the four configurations of the BSD-2000 and Sigma-60 applicator.

Figure 3. Average of (a) net integrated power (b), net integrated power per weight, and (c) vagina T50, over the years in primary cervical cancer patients treated with the four configurations of the BSD-2000 and Sigma-60 applicator.

Figure 4. Average frequency of power switched-off and each switched-off duration time per treatment over the 15 years.

Figure 4. Average frequency of power switched-off and each switched-off duration time per treatment over the 15 years.

Figure 5. Example of correlation between percentages of normalized net integrated power per pelvic area and percentages of normalized vagina T50. The slope of the trend line is 0.16 and the correlation coefficient is 0.9.

Figure 5. Example of correlation between percentages of normalized net integrated power per pelvic area and percentages of normalized vagina T50. The slope of the trend line is 0.16 and the correlation coefficient is 0.9.

Figure 6. Averages of (a) net integrated power and patients’ weight, and (b) vagina lumen T50 and patients’ weight over the last nine years of the study.

Figure 6. Averages of (a) net integrated power and patients’ weight, and (b) vagina lumen T50 and patients’ weight over the last nine years of the study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.